Precipio (PRPO) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Aug 17, 2026

Source: earnings call transcript

Precipio delivered record financial results as commercial traction across diagnostic products reinforced its self-funding laboratory flywheel model. Expanding distributor relationships and pipeline conversion drove double-digit top-line growth, inflecting cash generation and adjusted EBITDA without external dilutive financing.

You’re reading a preview. Opening the full call uses 1 concall credit.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.